Page last updated: 2024-10-22

amitriptyline and 2019 Novel Coronavirus Disease

amitriptyline has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Headache is one of the most frequently reported symptoms in post-COVID patients."5.72Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. ( Arias-Rivas, S; Gago-Veiga, AB; García-Azorín, D; Gonzalez-Martinez, A; Guerrero-Peral, ÁL; Sierra, Á; Silva, L, 2022)
"Headache is one of the most frequently reported symptoms in post-COVID patients."1.72Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. ( Arias-Rivas, S; Gago-Veiga, AB; García-Azorín, D; Gonzalez-Martinez, A; Guerrero-Peral, ÁL; Sierra, Á; Silva, L, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gonzalez-Martinez, A1
Guerrero-Peral, ÁL1
Arias-Rivas, S1
Silva, L1
Sierra, Á1
Gago-Veiga, AB1
García-Azorín, D1
Şahin, MF1
Özcan, R1
Malak, A1
Doğan, Ç1
Yazıcı, CM1
Özcan, M1
Akgül, M1

Other Studies

2 other studies available for amitriptyline and 2019 Novel Coronavirus Disease

ArticleYear
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors.
    Journal of neurology, 2022, Volume: 269, Issue:11

    Topics: Amitriptyline; COVID-19; Female; Headache; Humans; Male; Migraine Disorders; Nausea; Retrospective S

2022
The effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment.
    Neurourology and urodynamics, 2023, Volume: 42, Issue:6

    Topics: Amitriptyline; COVID-19; Cystitis, Interstitial; Female; Humans; Male; Pandemics; Urinary Bladder, O

2023